Amyotrophic Lateral Sclerosis Treatment Market: How Is Antisense Oligonucleotide Therapy Becoming the Fastest-Growing Precision Medicine Paradigm?
Antisense oligonucleotide (ASO) therapy for ALS — the gene-silencing precision medicines targeting SOD1, C9orf72, and FUS mutations to halt motor neuron degeneration at the RNA level — represents the fastest-expanding treatment category in the global ALS therapeutics landscape, with the Amyotrophic Lateral Sclerosis Treatment Market reflecting ASO therapy as the premium...
0 Comments 0 Shares 15 Views 0 Reviews